nodes	percent_of_prediction	percent_of_DWPC	metapath
Dipivefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.00408	0.00408	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.00404	0.00404	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.00394	0.00394	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—ANGPT2—focal segmental glomerulosclerosis	0.0039	0.0039	CbGpPWpGaD
Dipivefrin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—focal segmental glomerulosclerosis	0.00387	0.00387	CbGpPWpGaD
Dipivefrin—ADRA2C—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.00386	0.00386	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.00383	0.00383	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.00372	0.00372	CbGpPWpGaD
Dipivefrin—ADRA2B—Hemostasis—TRPC6—focal segmental glomerulosclerosis	0.00368	0.00368	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.00367	0.00367	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.00366	0.00366	CbGpPWpGaD
Dipivefrin—ADRA2B—G alpha (i) signalling events—AGT—focal segmental glomerulosclerosis	0.00366	0.00366	CbGpPWpGaD
Dipivefrin—ADRA1A—G alpha (q) signalling events—AGT—focal segmental glomerulosclerosis	0.00359	0.00359	CbGpPWpGaD
Dipivefrin—ADRA2B—Platelet activation, signaling and aggregation—FN1—focal segmental glomerulosclerosis	0.00355	0.00355	CbGpPWpGaD
Dipivefrin—ADRA2B—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.00351	0.00351	CbGpPWpGaD
Dipivefrin—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.00346	0.00346	CbGpPWpGaD
Dipivefrin—ADRA2C—Hemostasis—TRPC6—focal segmental glomerulosclerosis	0.00344	0.00344	CbGpPWpGaD
Dipivefrin—ADRA2C—G alpha (i) signalling events—AGT—focal segmental glomerulosclerosis	0.00342	0.00342	CbGpPWpGaD
Dipivefrin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.00338	0.00338	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.00335	0.00335	CbGpPWpGaD
Dipivefrin—ADRA2C—Platelet activation, signaling and aggregation—FN1—focal segmental glomerulosclerosis	0.00332	0.00332	CbGpPWpGaD
Dipivefrin—ADRA2C—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.00328	0.00328	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.00327	0.00327	CbGpPWpGaD
Dipivefrin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—focal segmental glomerulosclerosis	0.00321	0.00321	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.00315	0.00315	CbGpPWpGaD
Dipivefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.00314	0.00314	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.00311	0.00311	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.00311	0.00311	CbGpPWpGaD
Dipivefrin—ADRA2B—Hemostasis—GNAQ—focal segmental glomerulosclerosis	0.00308	0.00308	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism of proteins—ACE—focal segmental glomerulosclerosis	0.00297	0.00297	CbGpPWpGaD
Dipivefrin—ADRA2B—Platelet activation, signaling and aggregation—SERPINE1—focal segmental glomerulosclerosis	0.00296	0.00296	CbGpPWpGaD
Dipivefrin—ADRA2B—Platelet activation, signaling and aggregation—ALB—focal segmental glomerulosclerosis	0.00295	0.00295	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.00294	0.00294	CbGpPWpGaD
Dipivefrin—ADRA2B—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00291	0.00291	CbGpPWpGaD
Dipivefrin—ADRA2C—Hemostasis—GNAQ—focal segmental glomerulosclerosis	0.00288	0.00288	CbGpPWpGaD
Dipivefrin—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00287	0.00287	CbGpPWpGaD
Dipivefrin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.00286	0.00286	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—TRPC6—focal segmental glomerulosclerosis	0.0028	0.0028	CbGpPWpGaD
Dipivefrin—ADRA2A—G alpha (i) signalling events—AGT—focal segmental glomerulosclerosis	0.00278	0.00278	CbGpPWpGaD
Dipivefrin—ADRA2C—Platelet activation, signaling and aggregation—SERPINE1—focal segmental glomerulosclerosis	0.00276	0.00276	CbGpPWpGaD
Dipivefrin—ADRA2C—Platelet activation, signaling and aggregation—ALB—focal segmental glomerulosclerosis	0.00276	0.00276	CbGpPWpGaD
Dipivefrin—ADRA2C—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00272	0.00272	CbGpPWpGaD
Dipivefrin—ADRA2A—Platelet activation, signaling and aggregation—FN1—focal segmental glomerulosclerosis	0.0027	0.0027	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00267	0.00267	CbGpPWpGaD
Dipivefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.00266	0.00266	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism of proteins—ACE—focal segmental glomerulosclerosis	0.00265	0.00265	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00264	0.00264	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.00257	0.00257	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.00254	0.00254	CbGpPWpGaD
Dipivefrin—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	0.00253	0.00253	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00249	0.00249	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.00239	0.00239	CbGpPWpGaD
Dipivefrin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00238	0.00238	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—GNAQ—focal segmental glomerulosclerosis	0.00234	0.00234	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00233	0.00233	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00232	0.00232	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.0023	0.0023	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00229	0.00229	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.00227	0.00227	CbGpPWpGaD
Dipivefrin—ADRA2A—Platelet activation, signaling and aggregation—SERPINE1—focal segmental glomerulosclerosis	0.00224	0.00224	CbGpPWpGaD
Dipivefrin—ADRA2A—Platelet activation, signaling and aggregation—ALB—focal segmental glomerulosclerosis	0.00224	0.00224	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00222	0.00222	CbGpPWpGaD
Dipivefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00221	0.00221	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00219	0.00219	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00219	0.00219	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00218	0.00218	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.00218	0.00218	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00218	0.00218	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00216	0.00216	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00216	0.00216	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00211	0.00211	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.0021	0.0021	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00209	0.00209	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00208	0.00208	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00207	0.00207	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00204	0.00204	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00203	0.00203	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00201	0.00201	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00198	0.00198	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00198	0.00198	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00196	0.00196	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00195	0.00195	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.00194	0.00194	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00192	0.00192	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.0019	0.0019	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00189	0.00189	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism of proteins—AGT—focal segmental glomerulosclerosis	0.00188	0.00188	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00188	0.00188	CbGpPWpGaD
Dipivefrin—ADRA2B—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	0.00187	0.00187	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—LIPC—focal segmental glomerulosclerosis	0.00186	0.00186	CbGpPWpGaD
Dipivefrin—ADRA2B—Hemostasis—FN1—focal segmental glomerulosclerosis	0.00183	0.00183	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00182	0.00182	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00181	0.00181	CbGpPWpGaD
Dipivefrin—ADRA2B—Hemostasis—NOS2—focal segmental glomerulosclerosis	0.00181	0.00181	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00179	0.00179	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00178	0.00178	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00177	0.00177	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00177	0.00177	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00176	0.00176	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00176	0.00176	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00175	0.00175	CbGpPWpGaD
Dipivefrin—ADRA2C—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	0.00174	0.00174	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00173	0.00173	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00172	0.00172	CbGpPWpGaD
Dipivefrin—ADRA2C—Hemostasis—FN1—focal segmental glomerulosclerosis	0.00171	0.00171	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.0017	0.0017	CbGpPWpGaD
Dipivefrin—ADRA2C—Hemostasis—NOS2—focal segmental glomerulosclerosis	0.00169	0.00169	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00168	0.00168	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00168	0.00168	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism of proteins—AGT—focal segmental glomerulosclerosis	0.00168	0.00168	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.00167	0.00167	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00166	0.00166	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00166	0.00166	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—LIPC—focal segmental glomerulosclerosis	0.00166	0.00166	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00165	0.00165	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00164	0.00164	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—CTGF—focal segmental glomerulosclerosis	0.00163	0.00163	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00162	0.00162	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.0016	0.0016	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.0016	0.0016	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.0016	0.0016	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00159	0.00159	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00159	0.00159	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00153	0.00153	CbGpPWpGaD
Dipivefrin—ADRA2B—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	0.00152	0.00152	CbGpPWpGaD
Dipivefrin—ADRA2B—Hemostasis—ALB—focal segmental glomerulosclerosis	0.00152	0.00152	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00151	0.00151	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00151	0.00151	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.00151	0.00151	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00149	0.00149	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.00149	0.00149	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00148	0.00148	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism of proteins—MMP2—focal segmental glomerulosclerosis	0.00147	0.00147	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—CTGF—focal segmental glomerulosclerosis	0.00146	0.00146	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00145	0.00145	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00144	0.00144	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—LIPC—focal segmental glomerulosclerosis	0.00144	0.00144	CbGpPWpGaD
Dipivefrin—ADRA2C—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	0.00142	0.00142	CbGpPWpGaD
Dipivefrin—ADRA2C—Hemostasis—ALB—focal segmental glomerulosclerosis	0.00142	0.00142	CbGpPWpGaD
Dipivefrin—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	0.00142	0.00142	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00141	0.00141	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—FN1—focal segmental glomerulosclerosis	0.00139	0.00139	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00139	0.00139	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—NOS2—focal segmental glomerulosclerosis	0.00137	0.00137	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00137	0.00137	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00135	0.00135	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00135	0.00135	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.00134	0.00134	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00134	0.00134	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00132	0.00132	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism of proteins—MMP2—focal segmental glomerulosclerosis	0.00131	0.00131	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00129	0.00129	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00128	0.00128	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—CTGF—focal segmental glomerulosclerosis	0.00127	0.00127	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.00125	0.00125	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.00125	0.00125	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00124	0.00124	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.00124	0.00124	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.00123	0.00123	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00123	0.00123	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00123	0.00123	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00123	0.00123	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.00117	0.00117	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—LIPC—focal segmental glomerulosclerosis	0.00117	0.00117	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.00117	0.00117	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.00117	0.00117	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00116	0.00116	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	0.00116	0.00116	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—ALB—focal segmental glomerulosclerosis	0.00115	0.00115	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00115	0.00115	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.00114	0.00114	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—LPL—focal segmental glomerulosclerosis	0.00113	0.00113	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.00112	0.00112	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00112	0.00112	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.00106	0.00106	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.00104	0.00104	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00104	0.00104	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.00103	0.00103	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—CTGF—focal segmental glomerulosclerosis	0.00103	0.00103	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.00102	0.00102	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.00102	0.00102	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00101	0.00101	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—LPL—focal segmental glomerulosclerosis	0.00101	0.00101	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000975	0.000975	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—AGT—focal segmental glomerulosclerosis	0.000969	0.000969	CbGpPWpGaD
Dipivefrin—ADRA2B—Hemostasis—TGFB1—focal segmental glomerulosclerosis	0.000962	0.000962	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000955	0.000955	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000951	0.000951	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000948	0.000948	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000948	0.000948	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000943	0.000943	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000942	0.000942	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000929	0.000929	CbGpPWpGaD
Dipivefrin—ADRA2C—Hemostasis—TGFB1—focal segmental glomerulosclerosis	0.000899	0.000899	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000892	0.000892	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—LPL—focal segmental glomerulosclerosis	0.000878	0.000878	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—AGT—focal segmental glomerulosclerosis	0.000864	0.000864	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000863	0.000863	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000853	0.000853	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.00081	0.00081	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000799	0.000799	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000792	0.000792	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000786	0.000786	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.00078	0.00078	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000776	0.000776	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000756	0.000756	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—AGT—focal segmental glomerulosclerosis	0.000751	0.000751	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000744	0.000744	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—ALB—focal segmental glomerulosclerosis	0.000743	0.000743	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000735	0.000735	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000734	0.000734	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—TGFB1—focal segmental glomerulosclerosis	0.00073	0.00073	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000725	0.000725	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—LPL—focal segmental glomerulosclerosis	0.000713	0.000713	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000695	0.000695	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000672	0.000672	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000664	0.000664	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—ALB—focal segmental glomerulosclerosis	0.000663	0.000663	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000661	0.000661	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000642	0.000642	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000628	0.000628	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000621	0.000621	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000614	0.000614	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000613	0.000613	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—AGT—focal segmental glomerulosclerosis	0.00061	0.00061	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000608	0.000608	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000596	0.000596	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.00058	0.00058	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—ALB—focal segmental glomerulosclerosis	0.000576	0.000576	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000565	0.000565	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000549	0.000549	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000517	0.000517	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.00051	0.00051	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.00051	0.00051	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000507	0.000507	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000483	0.000483	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000471	0.000471	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—ALB—focal segmental glomerulosclerosis	0.000468	0.000468	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000422	0.000422	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000396	0.000396	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000392	0.000392	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000391	0.000391	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.00037	0.00037	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000326	0.000326	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000323	0.000323	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000322	0.000322	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000305	0.000305	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.0003	0.0003	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000266	0.000266	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000248	0.000248	CbGpPWpGaD
